Abstract
The management of testicular cancer has changed dramatically since the early 1980s because of highly effective chemotherapy and improvements in surgical technique. The long-term survival and cure rate even for advanced stages of all germ cell tumors is excellent. As such, there is now increased emphasis on developing treatment regimens that attain a high cure rate while minimizing patient morbidity.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lashley DB, Lowe BA. A rational approach to managing stage I nonseminomatous germ cell cancer. Urol Clin North Am 1998; 25: 405–423.
Sogani PC, Perrotti M, Herr HW, Fair WR, Thaler HT, Bosl G. Clinical stage I testis cancer: long-term outcome of patients on surveillance. J Urol 1998; 159: 855–858.
Foster RS, Roth BJ. Clinical stage I nonseminoma: surgery versus surveillance. Semin Oncol 1998; 25: 145–153.
Nicolai N, Pizzocaro G. A surveillance study of clinical stage I nonseminomatous germ cell tumors of the testis: 10-year followup. J Urol 1995; 154: 1045–1049.
Sturgeon JF, Jewett MA, Alison RE, et al. Surveillance after orchidectomy for patients with clinical stage I nonseminomatous testis tumors. J Clin Oncol 1992; 10: 564–568.
Gels ME, Hoekstra HJ, Sleijfer DT, et al. Detection of recurrence in patients with clinical stage I nonseminomatous testicular germ cell tumors and consequences for further follow-up: single-center 10-year experience. J Clin Oncol 1995; 13: 1188–1194.
Heidenreich A, Sesterhenn IA, Mostofi FK, Moul JW. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 1998; 83: 1002–1011.
Read G, Stenning SP, Cullen MH, et al. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party. J Clin Oncol 1992; 10: 1762–1768.
Foster RS, Donohue JP. Retroperitoneal lymph node dissection for the management of clinical stage I nonseminoma. J Urol 2000; 163: 1788–1792.
Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Complications of primary retroperitoneal lymph node dissection. J Urol 1994; 152: 424–427.
Donohue JP, Foster RS. Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing techniques. Urol Clin North Am 1998; 25: 461–468.
Donohue JP, Foster RS, Rowland RG, Bihrle R, Jones J, Geier G. Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation. J Urol 1990; 144: 287–291.
Winfield HN. Laparoscopic retroperitoneal lymphadenectomy for cancer of the testis. Urol Clin North Am 1998; 25: 469–478.
Gerber GS, Bissada NK, Hulbert JC, et al. Laparoscopic retroperitoneal lymphadenectomy: multi-institutional analysis. J Urol 1994; 152: 1188–1191.
Giusti G, Beltrami P, Tallarigo C, Bianchi G, Mobilio G. Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular cancer. J Endourol 1998; 12: 561–566.
Janetschek G, Hobisch A, Peschel R, Hittmair A, Bartsch G. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous testicular carcinoma: long-term outcome. J Urol 2000; 163: 1793–1796.
Janetschek G, Peschel R, Hobisch A, Bartsch G. Laparoscopic retroperitoneal lymph node dissection. J Endourol 2001; 15: 449–453.
Nelson JB, Chen RN, Bishoff JT, et al. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular tumors. Urology 1999; 54: 1064–1067.
Rassweiler JJ, Frede T, Lenz E, Seemann O, Alken P. Long-term experience with laparoscopic retroperitoneal lymph node dissection in the management of lowstage testis cancer. Eur Urol 2000; 37: 251–260.
Zhuo Y, Klaen R, Sauter TW, Miller K. Laparoscopic retroperitoneal lymph node dissection in clinical stage I nonseminomatous germ cell tumor: a minimal invasive alternative. Chin Med J (Engl) 1998; 111: 537–541.
Janetschek GJ, Hobisch A, Hittmair A, Holtl L, Peschel R, Bartsch G. Laparoscopic retroperitoneal lymphadenectomy after chemotherapy for stage IIB nonseminomatous testicular carcinoma. J Urol 1999; 161: 477–481.
Weissbach L, Boedefeld EA. Localization of solitary and multiple metastases in stage II nonseminomatous testis tumor as basis for a modified staging lymph node dissection in stage I. J Urol 1987; 138: 77–82.
Gaur DD. Laparoscopic operative retroperitoneoscopy: use of a new device. J Urol 1992; 148: 1137–1139.
Janetschek G, Hobisch A, Holtl L, Bartsch G. Retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular tumor: laparoscopy versus open surgery and impact of learning curve. J Urol 1996; 156: 89–93.
Klotz L. Laparoscopic retroperitoneal lymphadenectomy for high-risk stage 1 nonseminomatous germ cell tumor: report of four cases. Urology 1994; 43: 752–756.
Rukstalis DB, Chodak GW. Laparoscopic retroperitoneal lymph node dissection in a patient with stage 1 testicular carcinoma. J Urol 1992; 148: 1907–1909.
Stone NN, Schlussel RN, Waterhouse RL, Unger P. Laparoscopic retroperitoneal lymph node dissection in stage A nonseminomatous testis cancer. Urology 1993; 42: 610–614.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Wang, D.S., Winfield, H.N. (2004). Laparoscopic Retroperitoneal Lymph Node Dissection for Nonseminomatous Germ Cell Tumors of the Testis. In: Cadeddu, J.A. (eds) Laparoscopic Urologic Oncology. Current Clinical Urology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-425-2_10
Download citation
DOI: https://doi.org/10.1007/978-1-59259-425-2_10
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-4684-9803-5
Online ISBN: 978-1-59259-425-2
eBook Packages: Springer Book Archive